Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105M Sell
289,819
-149,244
-34% -$51.1M 0.52% 53
2026
Q1
$155M Sell
439,063
-20,330
-4% -$7.25M 0.8% 38
2025
Q4
$150M Buy
459,393
+4,809
+1% +$1.53M 0.77% 38
2025
Q3
$128M Buy
454,584
+16,646
+4% +$4.83M 0.68% 45
2025
Q2
$122M Buy
437,938
+19,708
+5% +$5.58M 0.67% 44
2025
Q1
$130M Sell
418,230
-22,600
-5% -$6.67M 0.62% 35
2024
Q4
$115M Buy
440,830
+157,813
+56% +$46.8M 0.71% 37
2024
Q3
$91.1M Buy
283,017
+246,568
+676% +$80.7M 0.33% 60
2024
Q2
$11.4M Buy
36,449
+9,572
+36% +$2.81M 0.04% 178
2024
Q1
$7.63M Buy
+26,877
New +$7.86M 0.03% 252

Other funds holding AMGN

M&G plc's AMGN Position: Q2 2026 in Review

M&G plc reduced its Amgen (AMGN) stake by 34% in Q2 2026, selling an estimated $51.1M and leaving 289,819 shares worth $105M. The position accounts for 0.52% of the portfolio, ranked #53.

M&G plc first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $155M in Q1 2026. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • M&G plc held 289,819 shares of Amgen worth $105M as of Q2 2026.
  • M&G plc sold 149,244 Amgen shares in Q2 2026, an estimated $51.1M.
  • Amgen made up 0.52% of M&G plc's portfolio in Q2 2026, its #53 holding.
  • M&G plc first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Amgen position peaked at $155M in Q1 2026.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.